📣 VC round data is live. Check it out!

VieMed Valuation Multiples

Discover revenue and EBITDA valuation multiples for VieMed and similar public comparables like TaiDoc Technology, Myriad Genetics, Delcath Systems, IVF hartmann and more.

VieMed Overview

About VieMed

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.


Founded

2016

HQ

United States

Employees

1.2K

Website

viemed.com

Financials (LTM)

Revenue: $289M
EBITDA: $64M

EV

$373M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

VieMed Financials

VieMed reported last 12-month revenue of $289M and EBITDA of $64M.

In the same LTM period, VieMed generated $166M in gross profit, $64M in EBITDA, and $16M in net income.

Revenue (LTM)


VieMed P&L

In the most recent fiscal year, VieMed reported revenue of $270M and EBITDA of $61M.

VieMed is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 23%, and net margin of 6%.

See analyst estimates for VieMed
LTMLast FY202320242025202620272028
Revenue$289M$270M$183M$224M$270M
Gross Profit$166M$155M$113M$133M$155M
Gross Margin57%58%62%59%58%
EBITDA$64M$61M$37M$42M$52M
EBITDA Margin22%23%20%19%19%
EBIT Margin9%8%8%7%8%
Net Profit$16M$15M$10M$11M$15M
Net Margin6%6%6%5%6%

Financial data powered by Morningstar, Inc.

VieMed Stock Performance

VieMed has current market cap of $370M, and enterprise value of $373M.

Market Cap Evolution


VieMed's stock price is $9.65.

VieMed share price decreased by 3.1% in the last 30 days, and increased by 45.1% in the last year.

VieMed has an EPS (earnings per share) of $0.39.

See more trading valuation data for VieMed
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$373M$370M0.0%-3.1%10.9%45.1%$0.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

VieMed Valuation Multiples

VieMed trades at 1.3x EV/Revenue multiple, and 5.8x EV/EBITDA.

See NTM and 2027E valuation multiples for VieMed

EV / Revenue (LTM)


VieMed Financial Valuation Multiples

As of May 26, 2026, VieMed has market cap of $370M and EV of $373M.

VieMed has a P/E ratio of 22.7x.

LTMLast FY202320242025202620272028
EV/Revenue1.3x1.4x2.0x1.7x1.4x
EV/EBITDA5.8x6.1x10.2x8.8x7.2x
EV/EBIT15.0x16.3x24.9x23.3x18.0x
EV/Gross Profit2.3x2.4x3.3x2.8x2.4x
P/E22.7x24.8x36.1x32.8x24.8x
EV/FCF31.2x19.5xn/m31.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified VieMed Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

VieMed Margins & Growth Rates

VieMed grew revenue by 17% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, VieMed reported gross margin of 58%, EBITDA margin of 23%, and net margin of 6%.

See estimated margins and future growth rates for VieMed

VieMed Margins

Last FY202420252026202720282029
Gross Margin58%59%58%57%
EBITDA Margin23%19%19%21%
EBIT Margin8%7%8%9%
Net Margin6%5%6%6%
FCF Margin4%1%4%

VieMed Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth17%23%21%17%
Gross Profit Growth16%18%17%16%
EBITDA Growth9%15%22%30%
EBIT Growth22%7%29%35%
Net Profit Growth23%10%33%23%
FCF Growth(93%)805%

Data powered by FactSet, Inc. and Morningstar, Inc.

VieMed Operational KPIs

VieMed's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

VieMed's Rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

VieMed's Rule of X is 65% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for VieMed
LTMLast FY202320242025202620272028
Rule of 4038%39%
Bessemer Rule of X61%65%
Revenue per Employee$0.2M
Opex per Employee$0.1M
G&A Expenses to Revenue48%51%50%48%
R&D Expenses to Revenue1%1%2%1%1%
Opex to Revenue50%53%52%50%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

VieMed Competitors

VieMed competitors include TaiDoc Technology, Myriad Genetics, Delcath Systems, IVF hartmann, Coltene, Universal Vision, Medipost, ClearPoint Neuro, Standard BioTools and Medios.

Most VieMed public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
TaiDoc Technology1.8x4.0x
Myriad Genetics0.5x0.5x11.5x11.6x
Delcath Systems3.4x3.2x11.6x17.8x
IVF hartmann1.2x7.4x
Coltene1.4x1.4x11.7x11.4x
Universal Vision2.4x2.3x5.2x5.3x
Medipost6.6x(6.2x)
ClearPoint Neuro10.0x8.5x(24.4x)(21.6x)

This data is available for Pro users. Sign up to see all VieMed competitors and their valuation data.

Start Free Trial

VieMed M&A Activity

VieMed has acquired 1 company to date.

Last acquisition by VieMed was on February 1st 2024. VieMed acquired Lehan Medical for $26M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by VieMed

Lehan Medical
Description
Lehan Medical supplies home medical equipment and pharmacy services in Owensboro, Kentucky. The store stocks mobility aids, oxygen therapy devices, and wellness products, delivering to patients in western Kentucky with insurance billing support.
HQ CountryUnited States
HQ City
DeKalb, IL
Deal Date1 Feb 2024
Valuation$26M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all VieMed acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About VieMed

When was VieMed founded?VieMed was founded in 2016.
Where is VieMed headquartered?VieMed is headquartered in United States.
How many employees does VieMed have?As of today, VieMed has over 1K employees.
Who is the CEO of VieMed?VieMed's CEO is Casey Hoyt.
Is VieMed publicly listed?Yes, VieMed is a public company listed on Nasdaq.
What is the stock symbol of VieMed?VieMed trades under VMD ticker.
When did VieMed go public?VieMed went public in 2018.
Who are competitors of VieMed?VieMed main competitors include TaiDoc Technology, Myriad Genetics, Delcath Systems, IVF hartmann, Coltene, Universal Vision, Medipost, ClearPoint Neuro, Standard BioTools, Medios.
What is the current market cap of VieMed?VieMed's current market cap is $370M.
What is the current revenue of VieMed?VieMed's last 12 months revenue is $289M.
What is the current revenue growth of VieMed?VieMed revenue growth (NTM/LTM) is 16%.
What is the current EV/Revenue multiple of VieMed?Current revenue multiple of VieMed is 1.3x.
Is VieMed profitable?Yes, VieMed is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of VieMed?VieMed's last 12 months EBITDA is $64M.
What is VieMed's EBITDA margin?VieMed's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of VieMed?Current EBITDA multiple of VieMed is 5.8x.
How many companies VieMed has acquired to date?As of May 2026, VieMed has acquired 1 company.
What was the largest acquisition by VieMed?$26M acquisition of Lehan Medical on 1st February 2024 was the largest M&A VieMed has done to date.
What companies VieMed acquired?VieMed acquired Lehan Medical.
In how many companies VieMed has invested to date?VieMed hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to VieMed

Lists including VieMed

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial